Neurontin, Rebetol Generics Could Be Affected By “Shared Exclusivity” Ruling

A federal court decision invalidating FDA's "shared exclusivity" policy for first-to-file ANDAs poses another potential complication to the launch of generic versions of Pfizer's Neurontin (gabapentin)